Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Theralase AUA Poster
View:
Post by Eoganacht on May 01, 2023 11:25am

Theralase AUA Poster

AUA 2023 Theralase Poster

It looks like data presentation is the same as the MD&A.
Comment by greaterfoolFred on May 01, 2023 11:49am
Stunning.  Did any of the authors read the poster?  How can they be serious?  I thought that maybe the numbers in the financial report table had been compiled from the  swimmers plot by some highs-chool intern.  But apparently not.  And now we have the data presented in a curve that doesn't match either the plot or the data.  Someone please help me understand ...more  
Comment by greaterfoolFred on May 01, 2023 11:53am
My mistake; the curve was there in the financial report.  I guess I was so stunned by the table that I didn't think about it.
Comment by DJDawg on May 01, 2023 12:06pm
Fred. Regardless of the data representation we can all agree: a) 90 day CR is 53.8% even if you include the under-treated. So likely higher. b) 90 day TR is 65.4% even if you include the under-treated. So likely higher. c) the proportion of the CR that stay CR till 450 is very good. d) there are a total of 13 other patients who were CR from day 90 and are still CR making for better and better ...more  
Comment by Infinity on May 01, 2023 1:16pm
There is some ambiguity in the way the Raw Data is presented on the Swimmer's plot.  I am hoping the Management has good reasons to present facts in a certain way that is acceptable to FDA.  Ultimately that is our common objective.  Going back and forth on this is only hurting the Stock price today.  I think, if we choose to wait for the AUA poster and discussion data and ...more  
Comment by DJDawg on May 01, 2023 1:24pm
I very much hope that they have hired an ex-FDA staff person turned consultant (lots of them I'm sure as would be quite lucrative) to hold their hands and tell them exactly what to do.
Comment by Alamir1111 on May 01, 2023 1:46pm
I think that's a good options Fact After the 90 day procedure 80% patients stay on 20% quit. ?? Long way to go till day 450 Those who stay have the 180 procedure 187 +- one day check up 210 +-. 7 day 240+- 14 day 360+- 14 day End of studs 450 day. Remember those treated are not young bucks anymore.  Different issues etc. Out of 50  some patients treated how many will finnish the 450 ...more  
Comment by Alamir1111 on May 01, 2023 1:58pm
I guess before applying for Btd an advisory commite will have to vote in favour of treatment to present Fda. Isnt that the normal procedure??
Comment by CancerSlayer on May 01, 2023 4:18pm
  Agree.... And once we get the final numbers, they certainly won't be set in stone once/if commercialized.  This ACT will continue to evolve & improve imo.   Interestingly, there have been 5 instances where an NR converted to a CR &/or IR.  Four of those cases ultimately ended back as NR & one has yet to be determined.  These cases indicate the ...more  
Comment by Alamir1111 on May 01, 2023 5:01pm
If we would get a 10x offer today 90%  of sh would go for it
Comment by enriquesuave on May 01, 2023 5:06pm
Lowest offer would be over $2 Billion USD. IMHO. That's a  25-30 bagger. 
Comment by Alamir1111 on May 01, 2023 5:16pm
Can't hardly wait to meet you guys in Vegas. But I aint humping no lion.
Comment by enriquesuave on May 01, 2023 5:21pm
Hopefully they are working on a Partnership deal to get upfront cash to speed up trial and get started on next indications.  If they raise $5 million that would be about 10% dilution. Not so bad for 10 -12 of cash months until a Partnership.  Will it be a small raise or Partnership?  Time will tell.
Comment by Rumpl3StiltSkin on May 01, 2023 5:59pm
Well, If they finish that BTD application pronto, get that in. We are waiting on FDA 2-3 months. Then they get a JV deal. Should be solid one at that point. Do they have the cash now to make it thru all that??
Comment by wildbird1 on May 01, 2023 6:23pm
enriquasuave, speaking of money, we must not forget that if the SP climb over 0.50$ and stay over0.50$, all the warrant that are at 0.50$ and lower will be exercised, and in 2023,24 TLT could have secured approximately $35 million just in warrant money.
Comment by enriquesuave on May 01, 2023 7:13pm
I'm just dying to excercise all my 50 and 35 cent warrants.  
Comment by 99942Apophis on May 01, 2023 6:26pm
My thoughts on that enriquesuave is if 5M or less could mean either its enough to get us to another financial raise at a higher SP or more probable enough to get us into a partnership that is in the works right now. I'm in hopes of the later.
Comment by gojotv! on May 02, 2023 1:26am
You're new here, huh? Your post got zero likes, as anyone who's been here a while would expect. We know what we've got here (the cure for tumour cancers and viruses, no biggie, lol) and we're pretty much waiting aroung for a minimum of $50/share, and all the FDA/BigPharma/paid basher action against this stock only confirms our love of it. I'm saying the bidding will start ...more  
Comment by Alamir1111 on May 02, 2023 2:08am
Respect your opptimizm   .but yore likes  don't mean much Ther is no cure for cancer only treatment  Sit tight suck some limond while you get your  check in bank
Comment by stocksnbonds458 on May 02, 2023 1:36am
Not a chance, at today's price a 10X would be only$2.40 per share. Not even close to being okayed by 90% of shareholders imo
Comment by Rumpl3StiltSkin on May 02, 2023 8:26am
I agree. Weaksauce!   At least $2B US as someone earlier said...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250